- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/60 - Three or more oxygen or sulfur atoms
Patent holdings for IPC class C07D 239/60
Total number of patents in this class: 94
10-year publication summary
|
5
|
7
|
12
|
6
|
5
|
12
|
2
|
3
|
4
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1498 |
7 |
| Bristol-myers Squibb Company | 4820 |
4 |
| Glaxosmithkline LLC | 535 |
3 |
| Shionogi & Co., Ltd. | 835 |
3 |
| Inflazome Limited | 85 |
3 |
| Acquist LLC | 11 |
3 |
| Carbocode S.A. | 31 |
3 |
| Takeda Pharmaceutical Company Limited | 2717 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2731 |
2 |
| Changzhou University | 191 |
2 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
2 |
| Nektar Therapeutics | 437 |
2 |
| Teva Pharmaceuticals International GmbH | 333 |
2 |
| Zhejiang University | 3264 |
2 |
| Nuhope LLC | 3 |
2 |
| Septerna, Inc. | 12 |
2 |
| Merck Patent GmbH | 5759 |
1 |
| FUJIFILM Corporation | 29817 |
1 |
| Toray Industries, Inc. | 7006 |
1 |
| President and Fellows of Harvard College | 6036 |
1 |
| Other owners | 46 |